Pathway hunting by random survival forests

Bioinformatics

Volumn 29, Issue 1, 2013, Pages 99-105

  Chen, Xi ^a   Ishwaran, Hemant ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ALGORITHM; ARTICLE; COLON TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; MORTALITY; OVARY TUMOR; SIGNAL TRANSDUCTION; SURVIVAL;

ALGORITHMS; COLONIC NEOPLASMS; FEMALE; HUMANS; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSCRIPTOME;

EID: 84871753828     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts643     Document Type: Article

References (49)

1. Albini, A. and Sporn, M.B. (2007) The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer, 7, 139-147. (Pubitemid 46160989)
2. Backes, C. et al. (2007) Genetrail-advanced gene set enrichment analysis. Nucleic Acids Res., 35, W186-W192.
3. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodological), 57, 289-300.
4. Bonome, T. et al. (2008) A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res., 68, 5478-5486.
5. Breiman, L. (2001) Random forests. Mach. Learn., 45, 5-32. (Pubitemid 32933532)
6. Chen, X. et al. (2008) Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes. Bioinformatics, 24, 2474-2481.
7. Chen, X. et al. (2010) An integrative pathway-based clinical-genomic model for cancer survival prediction. Stat. Probab. Lett., 80, 1313-1319.
8. Cordell, H.J. (2009) Detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet., 10, 392-404.
9. Diaz-Uriarte, R. and de Andres, S.A. (2006) Gene selection and classification of microarray data using random forest. BMC Bioinformatics, 7, 3.
10. Efron, B. and Tibshirani, R. (2007) On testing the significance of sets of genes. Ann. Appl. Stat., 1, 107-129.
11. Fulda, S. and Debatin, K.M. (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 25, 4798-4811. (Pubitemid 44187627)
12. Goeman, J.J. and Buhlmann, P. (2007) Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics, 23, 980-987. (Pubitemid 47050585)
13. Gupta, R.A. et al. (2004) Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat. Med., 10, 245-247. (Pubitemid 38667613)
14. Horvath, S. et al. (2006) Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet., 2, 1182-1192. (Pubitemid 44298493)
15. Huang, D.W. et al. (2009) Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat. Protoc., 4, 44-57.
16. Ishwaran, H. et al. (2008) Random survival forests. Ann. Appl. Stat., 2, 841-860.
17. Ishwaran, H. et al. (2009) A novel approach to cancer staging: application to esopha-geal cancer. Biostatistics, 10, 603-620.
18. Ishwaran, H. et al. (2010) High-dimensional variable selection for survival data. J. Am. Stat. Assoc., 105, 205-217.
19. Ishwaran, H. et al. (2011) Random survival forests for high-dimensional data. Stat. Anal. Data Mining, 4, 115-132.
20. Kim, S.Y. and Volsky, D.J. (2005) Page: parametric analysis of gene set enrichment. BMC Bioinformatics, 6, 144.
21. Krupp, M. et al. (2011) The functional cancer map: a systems-level synopsis of genetic deregulation in cancer. BMC Med. Genom., 4, 53.
22. Lee, C.H. et al. (2008) A novel mechanism of PPAR gamma regulation of TGF beta 1: implication in cancer biology. PPAR Res., 2008, 762398.
23. Liotta, L.A. and Kohn, E.C. (2001) The microenvironment of the tumour-host interface. Nature, 411, 375-379.
24. Lunetta, K.L. et al. (2004) Screening large-scale association study data: exploiting interactions using random forests. BMC Genet., 5, 32.
25. McCormick, F. (1999) Signaling networks that cause cancer. Trends Biochem. Sci., 24, M53-M56.
26. Michalik, L. et al. (2004) Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat. Rev. Cancer, 4, 61-70. (Pubitemid 38082154)
27. Moore, J.H. and Williams, S.M. (2009) Epistasis and its implications for personal genetics. Am. J. Hum. Genet., 85, 309-320.
28. Mootha et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphor-ylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273. (Pubitemid 36792858)
29. Nagamine, M. et al. (2003) PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells. Cancer Sci., 94, 338-343. (Pubitemid 36626365)
30. Newton, M.A. et al. (2007) Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis. Ann. Appl. Stat., 1, 85-106.
31. Ondrey, F. (2009) Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin. Cancer Res., 15, 2-8.
32. Pang, H. et al. (2006) Pathway analysis using random forests classification and regression. Bioinformatics, 22, 2028-2036. (Pubitemid 44283016)
33. Pang, H. et al. (2010) Pathway analysis using random forests with bivariate node-split for survival outcomes. Bioinformatics, 26, 250-258.
34. Qian, H. et al. (1998) Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem. Biophys. Res. Commun., 246, 660-667. (Pubitemid 28420915)
35. Rohrl, C. et al. (2011) Peroxisome-proliferator-activated receptors gamma and beta/delta mediate vascular endothelial growth factor production in colorectal tumor cells. J. Cancer Res. Clin. Oncol., 137, 29-39.
36. Sarraf, P. et al. (1998) Differentiation and reversal of malignant changes in colon cancer through ppar gamma. Nat. Med., 4, 1046-1052. (Pubitemid 28417337)
37. Schadt, E.E. et al. (2008) Variations in dna elucidate molecular networks that cause disease. Nature, 452, 429-435. (Pubitemid 351450844)
38. Shayesteh, L. et al. (1999) Pik3ca is implicated as an oncogene in ovarian cancer. Nat. Genet., 21, 99-102. (Pubitemid 29036292)
39. Smith, J.J. et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology, 138, 958-968.
40. Subramanian, A. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550. (Pubitemid 41528093)
41. Tian, L. et al. (2005) Discovering statistically significant pathways in expression profiling studies. Proc. Natl Acad. Sci. USA, 102, 13544-13549. (Pubitemid 41420885)
42. Tomfohr, J. et al. (2005) Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics, 6, 225.
43. Vucenik, I. and Shamsuddin, A.M. (2003) Cancer inhibition by inositol hexapho-sphate (ip6) and inositol: from laboratory to clinic. J. Nutr., 133, 3778S-3784S. (Pubitemid 37392600)
44. Wang, L. et al. (2008) An integrated approach for the analysis of biological pathways using mixed models. PLoS Genet., 4, e1000115.
45. Wang, L. et al. (2009) A unified mixed effects model for gene set analysis of time course microarray experiments. Stat. Appl. Genet. Mol. Biol., 8, Article 47.
46. Wasan, H.S. et al. (1997) Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl Acad. Sci. USA, 94, 3308-3313. (Pubitemid 27157307)
47. Weichselbaum, R.R. et al. (2008) An interferon-related gene signature for dna damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc. Natl Acad. Sci. USA, 105, 18490-18495.
48. Yamauchi, T. et al. (2003) Cloning of adiponectin receptors that mediate antidia-betic metabolic effects. Nature, 423, 762-769. (Pubitemid 36735700)
49. Yang, W.L. and Frucht, H. (2001) Activation of the ppar pathway induces apoptosis and cox-2 inhibition in ht-29 human colon cancer cells. Carcinogenesis, 22, 1379-1383. (Pubitemid 32898693)